110 related articles for article (PubMed ID: 2682872)
1. Prevention of chronic bronchitis exacerbations with ambroxol (mucosolvan retard). An open, long-term, multicenter study in 5,635 patients.
Respiration; 1989; 55 Suppl 1():84-96. PubMed ID: 2682872
[TBL] [Abstract][Full Text] [Related]
2. Ambroxol for the prevention of chronic bronchitis exacerbations: long-term multicenter trial. Protective effect of ambroxol against winter semester exacerbations: a double-blind study versus placebo.
Olivieri D; Zavattini G; Tomasini G; Daniotti S; Bonsignore G; Ferrara G; Carnimeo N; Chianese R; Catena E; Marcatili S
Respiration; 1987; 51 Suppl 1():42-51. PubMed ID: 3299567
[TBL] [Abstract][Full Text] [Related]
3. [Long-term therapy over 2 years with ambroxol (Mucosolvan) retard capsules in patients with chronic bronchitis. Results of a double-blind study of 180 patients].
Cegla UH
Prax Klin Pneumol; 1988 Sep; 42(9):715-21. PubMed ID: 3141915
[No Abstract] [Full Text] [Related]
4. [Clinical results in the treatment of chronic obstructive bronchitis with ambroxol in comparison with bromhexine (author's transl)].
Wiessmann KJ; Niemeyer K
Arzneimittelforschung; 1978; 28(5a):918-21. PubMed ID: 373777
[TBL] [Abstract][Full Text] [Related]
5. Ambroxol therapy in simple chronic bronchitis: effects on subjective symptoms and ventilatory function.
Ericsson CH; Juhász J; Jönsson E; Mossberg B
Eur J Respir Dis; 1986 Oct; 69(4):248-55. PubMed ID: 3545883
[TBL] [Abstract][Full Text] [Related]
6. Ambroxol and simple chronic bronchitis. Effects on subjective symptoms and ventilatory function.
Ericsson CH; Juhasz J; Jönsson E; Mossberg B
Respiration; 1987; 51 Suppl 1():33-6. PubMed ID: 3299565
[TBL] [Abstract][Full Text] [Related]
7. Ambroxol plus amoxicillin in the treatment of exacerbations of chronic bronchitis.
Peralta J; Poderoso JJ; Corazza C; Fernández M; Guerreiro RB; Wiemeyer JC
Arzneimittelforschung; 1987 Aug; 37(8):969-71. PubMed ID: 3675696
[TBL] [Abstract][Full Text] [Related]
8. A controlled trial of ambroxol in chronic bronchitis.
Guyatt GH; Townsend M; Kazim F; Newhouse MT
Chest; 1987 Oct; 92(4):618-20. PubMed ID: 3308343
[TBL] [Abstract][Full Text] [Related]
9. Effect of twelve-months therapy with oral ambroxol in preventing exacerbations in patients with COPD. Double-blind, randomized, multicenter, placebo-controlled study (the AMETHIST Trial).
Malerba M; Ponticiello A; Radaeli A; Bensi G; Grassi V
Pulm Pharmacol Ther; 2004; 17(1):27-34. PubMed ID: 14643168
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of myrtol standardized in acute bronchitis. A multi-centre, randomised, double-blind, placebo-controlled parallel group clinical trial vs. cefuroxime and ambroxol.
Matthys H; de Mey C; Carls C; Ryś A; Geib A; Wittig T
Arzneimittelforschung; 2000 Aug; 50(8):700-11. PubMed ID: 10994153
[TBL] [Abstract][Full Text] [Related]
11. Influence of ambroxol on tracheobronchial clearance in simple chronic bronchitis.
Ericsson CH; Juhász J; Mossberg B; Philipson K; Svartengren M; Camner P
Eur J Respir Dis; 1987 Mar; 70(3):163-70. PubMed ID: 3569448
[TBL] [Abstract][Full Text] [Related]
12. Prevention of acute exacerbations of chronic obstructive bronchitis with carbocysteine lysine salt monohydrate: a multicenter, double-blind, placebo-controlled trial.
Allegra L; Cordaro CI; Grassi C
Respiration; 1996; 63(3):174-80. PubMed ID: 8739489
[TBL] [Abstract][Full Text] [Related]
13. [Long-term treatment of chronic bronchitis with ambroxol].
Schöpp W
ZFA (Stuttgart); 1981 Sep; 57(26):1778-86. PubMed ID: 7303838
[No Abstract] [Full Text] [Related]
14. Ambroxol in the treatment of idiopathic respiratory distress syndrome. An interim report on a controlled double-blind multicenter study versus placebo.
Marini A; Franzetti M; Gios G; Flauto U; Arosio A; Maccabruni M; Rondini G; Chirico G; Giancola A; Console V
Respiration; 1987; 51 Suppl 1():60-7. PubMed ID: 3299568
[TBL] [Abstract][Full Text] [Related]
15. Clinical efficacy of ambroxol in the treatment of bronchial stasis. Clinical trial in 120 patients at two different doses.
Germouty J; Jirou-Najou JL
Respiration; 1987; 51 Suppl 1():37-41. PubMed ID: 3299566
[TBL] [Abstract][Full Text] [Related]
16. [Clinical experience with ambroxol syrup (author's transl)].
Göbel P; Rensch H
Arzneimittelforschung; 1978; 28(5a):929-31. PubMed ID: 581992
[TBL] [Abstract][Full Text] [Related]
17. Clinical trial of ambroxol (Mucosolvan) in Sjögren's syndrome.
Ichikawa Y; Tokunaga M; Shimizu H; Moriuchi J; Takaya M; Arimori S
Tokai J Exp Clin Med; 1988 Aug; 13(3):165-9. PubMed ID: 2978189
[TBL] [Abstract][Full Text] [Related]
18. [A controlled study on the action of a new formulation of ambroxol in asthmatiform bronchitis in children].
Baldini G; Gucci M; Tarò D; Memmini C
Minerva Pediatr; 1989 Feb; 41(2):91-5. PubMed ID: 2661989
[TBL] [Abstract][Full Text] [Related]
19. Effect of ELOM-080 on exacerbations and symptoms in COPD patients with a chronic bronchitis phenotype - a post-hoc analysis of a randomized, double-blind, placebo-controlled clinical trial.
Beeh KM; Beier J; Candler H; Wittig T
Int J Chron Obstruct Pulmon Dis; 2016; 11():2877-2884. PubMed ID: 27920515
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of the efficacy and safety of a combination drug containing ambroxol, guaifenesin, and levosalbutamol versus a fixed-dose combination of bromhexine/guaifenesin/salbutamol in the treatment of productive cough in adult patients with acute bronchitis].
Zaitsev AA; Leshchenko IV; Esaulova NA; Viktorova IA
Ter Arkh; 2023 Apr; 95(3):236-242. PubMed ID: 37167145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
